https://scholars.lib.ntu.edu.tw/handle/123456789/581891
標題: | Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace | 作者: | Lin C.-L. JIA-HORNG KAO |
公開日期: | 2017 | 出版社: | Springer India | 卷: | 11 | 期: | 1 | 起(迄)頁: | 31-33 | 來源出版物: | Hepatology International | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85008514557&doi=10.1007%2fs12072-016-9782-x&partnerID=40&md5=85e64e58b3c00b9fd7a95aeceeb18043 https://scholars.lib.ntu.edu.tw/handle/123456789/581891 |
ISSN: | 1936-0533 | DOI: | 10.1007/s12072-016-9782-x | SDG/關鍵字: | antineoplastic agent; antivirus agent; hepatitis B core antibody; hepatitis B core antigen; hepatitis B surface antigen; immunosuppressive agent; rituximab; virus DNA; acute hepatitis A; acute hepatitis B; allogeneic hematopoietic stem cell transplantation; cancer chemotherapy; cancer patient; cancer prognosis; chronic hepatitis B; disease exacerbation; Editorial; hematologic malignancy; Hepatitis B virus; high risk patient; human; immunosuppressive treatment; incidence; infection prevention; inflammatory bowel disease; liver cell damage; lymphoma; nonhuman; pathogenesis; population risk; practice guideline; prospective study; rheumatoid arthritis; risk benefit analysis; seroprevalence; virus cell interaction; virus reactivation; virus replication; chronic hepatitis B; hematopoietic stem cell transplantation; Hepatitis B virus; immunology; immunosuppressive treatment; mass screening; physiology; procedures; virology; virus activation; Hematopoietic Stem Cell Transplantation; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppression; Mass Screening; Virus Activation |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。